Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results

Go back to Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 4.01 -0.24 (5.65%)
Previous Close $4.25    52 Week High
Open $4.21    52 Week Low
Day High $4.21    P/E N/A 
Day Low $3.98    EPS
Volume 553,563